Please assess the completion status of the following clinical trial:

Trial Title: Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* End-stage renal disease undergoing maintenance hemodialysis at KUMC outpatient hemodialysis unit~* Dialysis vintage of at least 6 months duration~* Nutritional vitamin D deficiency, defined as 25(OH)D \<25 ng/ml~* Age 21 to 88 years~Exclusion Criteria:~* Active infection~* Recent hospitalization for acute illness (within last 1 month)~* Refusal to study participation~* Poorly controlled secondary hyperparathyroidism (iPTH\>500)~* History of chronic inflammatory disease process, such as inflammatory bowel, rheumatoid arthritis, lupus, etc.~* Cinacalcet therapy~* Previous allergy to ergocalciferol~* History of parathyroidectomy~* Current treatment with immunosuppressant medications~* Noncompliance with prescribed hemodialysis regimen (i.e. skipping treatments, ending sessions early)~* Functional renal transplant within the last five years

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 88 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Cholecalciferol (Vitamin D)

Based on this trial design, predict the completion outcome and termination type (if applicable).